These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7729181)

  • 21. Morphologic changes in arterial grafts in rabbit ears.
    Reddy GS; Cliff WJ
    Lab Invest; 1979 Jan; 40(1):109-21. PubMed ID: 762951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic allograft nephropathy is prevented by inhibition of platelet-derived growth factor receptor: tyrosine kinase inhibitors as a potential therapy.
    Savikko J; Taskinen E; Von Willebrand E
    Transplantation; 2003 Apr; 75(8):1147-53. PubMed ID: 12717194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue-engineered blood vessel graft produced by self-derived cells and allogenic acellular matrix: a functional performance and histologic study.
    Yang D; Guo T; Nie C; Morris SF
    Ann Plast Surg; 2009 Mar; 62(3):297-303. PubMed ID: 19240529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune response to xenogeneic matrix grafts used in pediatric surgery.
    Meyer T; Meyer B; Schwarz K; Höcht B
    Eur J Pediatr Surg; 2007 Dec; 17(6):420-5. PubMed ID: 18072029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
    Guillonneau C; Aubry V; Renaudin K; Séveno C; Usal C; Tezuka K; Anegon I
    Transplantation; 2005 Aug; 80(4):546-54. PubMed ID: 16220623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic rejection in experimental cardiac transplantation in a rat model.
    Karnovsky MJ; Russell ME; Hancock W; Sayegh MH; Adams DH
    Clin Transplant; 1994 Jun; 8(3 Pt 2):308-12. PubMed ID: 8061372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibility of corneal allografts and xenografts to antibody-mediated rejection.
    Holán V; Vítová A; Krulová M; Zajícová A; Neuwirth A; Filipec M; Forrester JV
    Immunol Lett; 2005 Sep; 100(2):211-3. PubMed ID: 15869803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphocyte interactions with extracellular matrix proteins and endothelium in renal allograft recipients.
    Nowaczyk M; Górski A; Korczak-Kowalska G; Wierzbicki P; Wyzgał J; Durlik M; Orłowska A
    Arch Immunol Ther Exp (Warsz); 1998; 46(1):35-8. PubMed ID: 9510944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokine and alloantibody networks in long term cardiac allografts in rat recipients treated with rapamycin.
    Wasowska B; Wieder KJ; Hancock WW; Zheng XX; Berse B; Binder J; Strom TB; Kupiec-Weglinski JW
    J Immunol; 1996 Jan; 156(1):395-404. PubMed ID: 8598490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Revitalization of bovine xenografts used for experimental arterial replacement in dogs (author's transl)].
    Schölzel E; Petropoulos P; Spycher M; Uhlschmid G
    Thoraxchir Vask Chir; 1978 Jun; 26(3):177-82. PubMed ID: 675654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of lysyl oxidases in neointima development in vascular allografts.
    Rodríguez M; Pascual G; Cifuentes A; Perez-Köhler B; Bellón JM; Buján J
    J Vasc Res; 2011; 48(1):43-51. PubMed ID: 20606470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-free xenogenic vascular grafts fixed with glutaraldehyde or genipin: in vitro and in vivo studies.
    Chang Y; Hsu CK; Wei HJ; Chen SC; Liang HC; Lai PH; Sung HW
    J Biotechnol; 2005 Nov; 120(2):207-19. PubMed ID: 16112218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of crosslinking in modification of the immune response elicited against xenogenic vascular acellular matrices.
    Courtman DW; Errett BF; Wilson GJ
    J Biomed Mater Res; 2001 Jun; 55(4):576-86. PubMed ID: 11288086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of arterial remodeling in chronic allograft vasculopathy.
    Zheng Q; Liu S; Song Z
    Front Med; 2011 Sep; 5(3):248-53. PubMed ID: 21964706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental preparation of deantigenized vascular heterografts and study of tolerance after transplantation.
    Ionescu G; Neumann E; Domokos M; Andercou A; Cardan E; Cucu A
    Acta Chir Belg; 1977; 76(4):393-9. PubMed ID: 562571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arterial homografts.
    Callow AD
    Eur J Vasc Endovasc Surg; 1996 Oct; 12(3):272-81. PubMed ID: 8896468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical studies of hemodialysis access through formaldehyde-fixed arterial allografts.
    Liu Z; Zhu B; Wang X; Jing Y; Wang P; Wang S; Xu H
    Kidney Int; 2007 Nov; 72(10):1249-54. PubMed ID: 17687254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The fate of the freeze-preserved xenograft: an experimental study on rabbits, cats, and dogs.
    Siegal A; Siegal B; Slater B
    J Cardiovasc Surg (Torino); 1989; 30(1):76-80. PubMed ID: 2925779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphological and functional alterations in glycerol preserved rat aortic allografts.
    Fahner PJ; Idu MM; Legemate DA; Vanbavel E; Borstlap J; Pfaffendorf M; van Marle J; van Gulik TM
    Int J Artif Organs; 2004 Nov; 27(11):979-89. PubMed ID: 15636056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formaldehyde-fixed arterial allograft as a novel vascular access alternative in end-stage renal disease patients.
    Canaud B
    Kidney Int; 2007 Nov; 72(10):1179-81. PubMed ID: 17972906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.